Twist bioscience corp (TWST)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17
Revenues

65,797

60,057

54,385

47,056

39,997

32,606

25,427

0

0

0

Operating expenses:
Cost of revenues

51,136

49,361

47,426

44,133

40,242

36,548

32,189

0

0

0

Research and development

40,429

38,707

35,683

31,252

27,513

23,317

20,347

0

0

0

Selling, general and administrative

99,338

91,272

80,126

68,656

58,592

49,446

43,450

0

0

0

Litigation settlement

0

0

-

-

-

-

-

-

-

-

Total operating expenses

213,403

201,840

163,235

144,041

126,347

109,311

95,986

0

0

0

Loss from operations

-147,606

-141,783

-108,850

-96,985

-86,350

-76,705

-70,559

0

0

0

Interest income

2,733

2,932

3,032

2,652

2,132

1,505

999

0

0

0

Interest expense

1,069

1,194

1,294

1,392

1,411

1,388

1,313

0

0

0

Other income (expense), net

-298

-337

-265

-308

-95

-117

-121

0

0

0

Loss before income taxes

-146,240

-140,382

-107,377

-96,033

-85,724

-76,705

-70,994

0

0

0

Provision for income taxes

263

286

292

257

274

233

242

0

0

0

Net loss attributable to common stockholders

-146,503

-140,668

-107,669

-96,290

-85,998

-76,938

-71,236

0

0

0

Other comprehensive loss:
Change in unrealized gain on investments

64

72

49

0

0

0

-

-

0

0

Foreign currency translation adjustment

285

94

45

33

-203

-12

54

0

0

0

Comprehensive loss

-146,154

-140,502

-107,575

-96,241

-86,188

-76,956

-71,182

0

0

0

Net loss per share attributable to common stockholders—basic and diluted

-0.85

-1.69

-0.89

-0.92

-0.93

-1.18

-6.59

-6.18

-6.32

-6.42

Weighted average shares used in computing net loss per share attributable to common stockholders—basic and diluted

37,163

32,976

79,510,146

30,290,150

27,891

19,187

3,013,819

2,849,544

2,669,541

2,638,068